MARKET

XPH

XPH

SPDR® S&P Pharmaceuticals ETF
NYSEARCA
39.46
-0.34
-0.84%
Opening 15:31 04/24 EDT
OPEN
39.50
PREV CLOSE
39.79
HIGH
39.59
LOW
39.34
VOLUME
9.08K
TURNOVER
0
52 WEEK HIGH
45.62
52 WEEK LOW
34.38
TOTAL ASSET
192.88M
YTD YIELD
-5.27%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at XPH last week (0415-0419)?
Weekly Report · 2d ago
Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management
Home Market Outlook Today's Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management. Neuberger Berman: U.S. Economic growth has remained resilient and leads the world. Global Industrial Activity Is Picking Up While Early Signs Of Moderating Growth in Europe. We believe extreme market consensus presents a moment for active management.
Seeking Alpha · 04/15 13:50
Weekly Report: what happened at XPH last week (0408-0412)?
Weekly Report · 04/15 12:00
Weekly Report: what happened at XPH last week (0401-0405)?
Weekly Report · 04/08 12:06
Weekly Report: what happened at XPH last week (0325-0329)?
Weekly Report · 04/01 12:03
XPH: A More Balanced Way To Get Exposure To Pharmaceuticals
The SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. Pharmaceuticals sector. The top holdings of XPH include Axsome Therapeutics, Eli Lilly, Merck & Co., Pfizer, and Jazz Pharmaceuticals. XPH is a good option for investing in the pharmaceuticals industry.
Seeking Alpha · 03/28 14:38
Weekly Report: what happened at XPH last week (0318-0322)?
Weekly Report · 03/25 12:07
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 03/22 15:15
More
Profile
Fund Name
SPDR® S&P Pharmaceuticals ETF
Inception Date
2006-06-19
Benchmark
S&P Pharms Select Industry TR USD
Advisor Company
SSgA Funds Management Inc
Custodian
State Street Bank and Trust Co
Manager
Michael Feehily, Keith Richardson, Karl Schneider